HCA Healthcare/USF Morsani College of Medicine GME/Regional Medical Center Bayonet Point, 14000 Fivay Rd, Hudson, FL, 34667, USA.
WESMDPA Glaucoma Service, Baptist Medical Center, 311 Camden St, Ste 306, San Antonio, TX, 78215, USA.
Graefes Arch Clin Exp Ophthalmol. 2022 Oct;260(10):3331-3337. doi: 10.1007/s00417-022-05670-1. Epub 2022 Apr 20.
Iris incarceration is a complication of glaucoma filtering surgery that often requires surgery. We describe a technique for reduction of incarcerated iris at the slit lamp, dubbed rotational extraction of incarcerated iris (REII). A retrospective analysis of visual function and intraocular pressure (IOP) was done in patients treated with REII after nonpenetrating deep sclerectomy.
We retrospectively evaluated a cohort of patients who received REII for iris incarceration after nonpenetrating deep sclerectomy for glaucoma. IOP (applanation) and visual acuity (VA) were measured day-of, and 1, 3, 6, and 12 months post-REII. Adverse events were recorded. Kaplan-Meier survival analysis was done with definitions of IOP control at 15, 18, and 21 mmHg.
Forty-one eyes of 41 patients were treated with REII. Median time to iris incarceration from glaucoma surgery was 50 days (range 1-1906). Mean pre-REII IOP ± SD was 33.7 ± 14.1 mmHg, which reduced to 11.5 ± 6.1 mmHg day-of. LogMAR VA was 0.72 ± 0.8 log units at baseline and was unchanged at 12 months (P = 0.53). Survival analysis demonstrated varying efficacy depending on the definition of success. 79.0 to 92.2% of eyes achieved IOP control immediately after REII, 39.5 to 71.1% at 1 month, 26.3 to 52.6% at 3 months, 21.1 to 44.3% at 6 months, and 10.5 to 38.0% at 12 months. Nearly half (47.4%) of eyes required a tube shunt by 12 months.
REII may be a safe, minimally invasive slit lamp procedure that can reduce incarcerated iris and delay more invasive intervention for 3-6 months in most eyes.
虹膜嵌顿是青光眼滤过性手术的一种并发症,通常需要手术治疗。我们描述了一种在裂隙灯显微镜下降低嵌顿虹膜的技术,称为旋转提取嵌顿虹膜(REII)。对接受非穿透性深层巩膜切除术治疗后接受 REII 治疗的患者的视力功能和眼内压(IOP)进行回顾性分析。
我们回顾性评估了一组因青光眼接受非穿透性深层巩膜切除术治疗后接受 REII 治疗的虹膜嵌顿患者。在 REII 治疗后第 1、3、6 和 12 个月测量眼压(压平)和视力(VA)。记录不良事件。采用 Kaplan-Meier 生存分析,定义 15、18 和 21mmHg 时的眼压控制。
41 例患者的 41 只眼接受了 REII 治疗。从青光眼手术到虹膜嵌顿的中位时间为 50 天(范围 1-1906 天)。REII 治疗前的平均眼压 ±标准差为 33.7±14.1mmHg,术后第 1 天降低至 11.5±6.1mmHg。基线时 logMAR VA 为 0.72±0.8 对数单位,12 个月时无变化(P=0.53)。生存分析表明,根据成功的定义,疗效不同。79.0%至 92.2%的眼在 REII 治疗后立即获得眼压控制,1 个月时为 39.5%至 71.1%,3 个月时为 26.3%至 52.6%,6 个月时为 21.1%至 44.3%,12 个月时为 10.5%至 38.0%。近一半(47.4%)的眼在 12 个月时需要管分流。
REII 可能是一种安全、微创的裂隙灯手术,可以降低嵌顿虹膜的风险,并在大多数眼中延迟 3-6 个月的侵袭性干预。